|
1
|
Kuwano K, Araya J, Hara H, Minagawa S,
Takasaka N, Ito S, Kobayashi K and Nakayama K: Cellular senescence
and autophagy in the pathogenesis of chronic obstructive pulmonary
disease (COPD) and idiopathic pulmonary fibrosis (IPF). Respir
Investig. 54:397–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shimizu H, Bolati D, Adijiang A, Muteliefu
G, Enomoto A, Nishijima F, Dateki M and Niwa T: NF-κB plays an
important role in indoxyl sulfate-induced cellular senescence,
fibrotic gene expression, and inhibition of proliferation in
proximal tubular cells. Am J Physiol Cell Physio. 301:C1201–C1212.
2011. View Article : Google Scholar
|
|
3
|
Lansu K and Gentile S: Potassium channel
activation inhibits proliferation of breast cancer cells by
activating a senescence program. Cell Death Dis. 4:e6522013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma J, Hu X, Liao C, Xiao H, Zhu Q, Li Y,
Liu Z, Tao A, He Z, Xu C and Zheng K: Gypenoside L inhibits
proliferation of liver and esophageal cancer cells by inducing
senescence. Molecules. 24:10542019. View Article : Google Scholar :
|
|
5
|
Schosserer M, Grillari J and Breitenbach
M: The dual role of cellular senescence in developing tumors and
their response to cancer therapy. Front Oncol. 7:2782017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kurz DJ, Decary S, Hong Y and Erusalimsky
JD: Senescence-associated (beta)-galactosidase reflects an increase
in lysosomal mass during replicative ageing of human endothelial
cells. J Cell Sci. 113(Pt 20): 3613–3622. 2000.PubMed/NCBI
|
|
7
|
Dimri GP, Lee X, Basile G, Acosta M, Scott
G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O,
et al: A biomarker that identifies senescent human cells in culture
and in aging skin in vivo. Proc Natl Acad Sci USA. 92:9363–9367.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sosińska P, Mikuła-Pietrasik J, Ryżek M,
Naumowicz E and Książek K: Specificity of cytochemical and
fluorescence methods of senescence-associated β-galactosidase
detection for ageing driven by replication and time.
Biogerontology. 15:407–413. 2014. View Article : Google Scholar
|
|
9
|
Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz
DP, Goldstein J, Nelson PS, Desprez PY and Campisi J:
Senescence-associated secretory phenotypes reveal
cell-nonautonomous functions of oncogenic RAS and the p53 tumor
suppressor. PLoS Biol. 6:2853–2868. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ovadya Y and Krizhanovsk V: Senescent
cells: SASPected drivers of age-related pathologies.
Biogerontology. 15:627–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Donate LE and Blasco MA: Telomeres in
cancer and ageing. Philos Trans R Soc Lond B Biol Sci. 366:76–84.
2011. View Article : Google Scholar :
|
|
12
|
Muller HJ: The Remaking of Chromosomes.
The Collecting Net, Woods Hole. 13:181–198. 1938.
|
|
13
|
Leontieva OV and Blagosklonny MV: Tumor
promoter-induced cellular senescence: Cell cycle arrest followed by
geroconversion. Oncotarget. 5:12715–12727. 2014. View Article : Google Scholar
|
|
14
|
Chien M, Rinker-Schaeffer C and Stadler
WM: A G2/M growth arrest response to low-dose intermittent H2O2 in
normal uroepithelial cells. Int J Oncol. 17:425–432.
2000.PubMed/NCBI
|
|
15
|
Campisi J and Fabrizio FD: Cellular
senescence: When bad things happen to good cells. Nat Rev Mol Cell
Biol. 8:729–740. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin HK, Chen Z, Wang G, Nardella C, Lee
SW, Chan CH, Yang WL, Wang J, Egia A, Nakayama KI, et al: Skp2
targeting suppresses tumorigenesis by Arf-p53-independent cellular
senescence. Nature. 464:374–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vigneron A and Vousden KH: p53, ROS and
senescence in the control of aging. Aging (Albany NY). 2:471–474.
2010. View Article : Google Scholar
|
|
18
|
Kochetkova EY, Blinova GI, Bystrova OA,
Martynova MG, Pospelov VA and Pospelova TV: Targeted elimination of
senescent Ras-transformed cells by suppression of MEK/ERK pathway.
Aging (Albany NY). 9:2352–2375. 2017. View Article : Google Scholar
|
|
19
|
Mooi WJ and Peeper DS: Oncogene-induced
cell senescence-halting on the road to cancer. N Engl J Med.
355:1037–1046. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Braig M and Schmitt CA: Oncogene-induced
senescence: Putting the brakes on tumor development. Cancer Res.
66:2881–2884. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Z, Trotman LC, Shaffer D, Lin HK,
Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al:
Crucial role of p53-dependent cellular senescence in suppression of
Pten-deficient tumorigenesis. Nature. 436:725–730. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alimonti A, Nardella C, Chen Z, Clohessy
JG, Carracedo A, Trotman LC, Cheng K, Varmeh S, Kozma SC, Thomas G,
et al: A novel type of cellular senescence that can be enhanced in
mouse models and human tumor xenografts to suppress prostate
tumorigenesis. J Clin Invest. 120:681–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peeper DS: PICS-ure This: Prosenescence
Therapy? Cancer Cell. 17:219–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tato-Costa J, Casimiro S, Pacheco T, Pires
R, Fernandes A, Alho I, Pereira P, Costa P, Castelo HB, Ferreira J
and Costa L: Therapy-induced cellular senescence induces
epithelial-to-mesenchymal transition and increases invasiveness in
rectal cancer. Clin Colorectal Cancer. 15:170–178. 2016. View Article : Google Scholar
|
|
25
|
Gewirtz DA, Holt SE and Elmore LW:
Accelerated senescence: An emerging role in tumor cell response to
chemotherapy and radiation. Biochem Pharmacol. 76:947–957. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tonnessen-Murray CA, Lozano G and Jackson
JG: The regulation of cellular functions by the p53 protein:
Cellular senescence. Cold Spring Harb Perspect Med. 7:a0261122017.
View Article : Google Scholar
|
|
27
|
Rodier F and Campisi J: Four faces of
cellular senescence. J Cell Biol. 192:547–556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meiyanto E, Putri H, Larasati YA, Utomo
RY, Jenie RI, Ikawati M, Lestari B, Yoneda-Kato N, Nakamae I,
Kawaichi M and Kato JY: Anti-proliferative and anti-metastatic
potential of curcumin analogue, pentagamavunon-1 (PGV-1), toward
highly metastatic breast cancer cells in correlation with ROS
generation. Adv Pharm Bull. 9:445–452. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dasgupta J, Kar S, Liu R, Joseph J,
Kalyanaraman B, Remington SJ, Chen C and Melendez JA: Reactive
oxygen species control senescence-associated matrix
metalloproteinase-1 through c-Jun-N-terminal kinase. J Cell
Physiol. 225:52–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Acosta JC and Gil J: A role for CXCR2 in
senescence, but what about in cancer? Cancer Res. 69:2167–2170.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ortiz-Montero P, Londoño-Vallejo A and
Vernot JP: Senescence-associated IL-6 and IL-8 cytokines induce a
self- and cross-reinforced senescence/inflammatory milieu
strengthening tumorigenic capabilities in the MCF-7 breast cancer
cell line. Cell Commun Signal. 15:172017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carrière C, Gore AJ, Norris AM, Gunn JR,
Young AL, Longnecker DS and Korc M: Deletion of Rb accelerates
pancreatic carcinogenesis by oncogenic kras and impairs senescence
in premalignant lesions. Gastroenterology. 141:1091–1101. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Malaquin N, Vercamer C, Bouali F, Martien
S, Deruy E, Wernert N, Chwastyniak M, Pinet F, Abbadie C and
Pourtier A: Senescent fibroblasts enhance early skin carcinogenic
events via a paracrine MMP-PAR-1 axis. PLoS One. 8:e636072013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen F, Long Q, Fu D, Zhu D, Ji Y, Han L,
Zhang B, Xu Q, Liu B, Li Y, et al: Targeting SPINK1 in the damaged
tumour micro-environment alleviates therapeutic resistance. Nat
Commun. 9:43152018. View Article : Google Scholar
|
|
35
|
Zhang B, Fu D, Xu Q, Cong X, Wu C, Zhong
X, Ma Y, Lv Z, Chen F, Han L, et al: The senescence-associated
secretory phenotype is potentiated by feedforward regulatory
mechanisms involving Zscan4 and TAK1. Nat Commun. 9:17232018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nacarelli T, Lau L, Fukumoto T, Zundell J,
Fatkhutdinov N, Wu S, Aird KM, Iwasaki O, Kossenkov AV, Schultz D,
et al: NAD+ metabolism governs the proinflammatory
senescence-associated secretome. Nat Cell Biol. 21:397–407. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu Q, Long Q, Zhu D, Fu D, Zhang B, Han L,
Qian M, Guo J, Xu J, Cao L, et al: Targeting amphiregulin (AREG)
derived from senescent stromal cells diminishes cancer resistance
and averts programmed cell death 1 ligand (PD-L1)-mediated
immunosuppression. Aging Cell. 18:e130272019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang ST, Huang SW, Liu KT, Lee TY, Shieh
JJ and Wu CY: Atorvastatin-induced senescence of hepatocellular
carcinoma is mediated by downregulation of hTERT through the
suppression of the IL-6/STAT3 pathway. Cell Death Discov. 6:172020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miyazoe Y, Miuma S, Miyaaki H, Kanda Y,
Nakashiki S, Sasaki R, Haraguchi M, Shibata H, Honda T, Taura N and
Nakao K: Extracellular vesicles from senescent hepatic stellate
cells promote cell viability of hepatoma cells through increasing
EGF secretion from differentiated THP-1 cells. Biomed Rep.
12:163–170. 2020.PubMed/NCBI
|
|
40
|
Prattichizzol F, Giuliani A, Recchioni R,
Bonafè M, Marcheselli F, De Carolis S, Campanati A, Giuliodori K,
Rippo MR, Brugè F, et al: Anti-TNF-α treatment modulates SASP and
SASP-related microRNAs in endothelial cells and in circulating
angiogenic cells. Oncotarget. 7:11945–11958. 2016. View Article : Google Scholar
|
|
41
|
Xu M, Tchkonia T, Ding H, Ogrodnik M,
Lubbers ER, Pirtskhalava T, White TA, Johnson KO, Stout MB, Mezera
V, et al: JAK inhibition alleviates the cellular senescence
associated secretory phenotype and frailty in old age. Proc Natl
Acad Sci USA. 112:E6301–E6310. 2015. View Article : Google Scholar
|
|
42
|
Alimbetov D, Davis T, Brook AJ, Cox LS,
Faragher RG, Nurgozhin T, Zhumadilov Z and Kipling D: Suppression
of the senescence-associated secretory phenotype (SASP) in human
fibroblasts using small molecule inhibitors of p38 MAP kinase and
MK2. Biogerontology. 17:305–315. 2016. View Article : Google Scholar :
|
|
43
|
Herranz N, Gallage S, Mellone M,
Wuestefeld T, Klotz S, Hanley CJ, Raguz S, Acosta JC, Innes AJ,
Banito A, et al: mTOR regulates MAPKAPK2 translation to control the
senescence-associated secretory phenotype. Nat Cell Biol.
17:1205–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tsubouchi K, Araya J and Kuwano K:
PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.
Inflamm Regen. 38:182018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu S, Uppal H, Demaria M, Desprez PY,
Campisi J and Kapahi P: Simvastatin suppresses breast cancer cell
proliferation induced by senescent cells. Sci Rep. 5:178952015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang C, Vegna S, Jin H, Benedict B,
Lieftink C, Ramirez C, de Oliveira RL, Morris B, Gadiot J, Wang W,
et al: Inducing and exploiting vulnerabilities for the treatment of
liver cancer. Nature. 574:268–272. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Guerrero A, Herranz N, Sun B, Wagner V,
Gallage S, Guiho R, Wolter K, Pombo J, Irvine EE, Innes AJ, et al:
Cardiac glycosides are broad-spectrum senolytics. Nat Metab.
1:1074–1088. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hickson LJ, Langhi Prata LGP, Bobart SA,
Evans TK, Giorgadze N, Hashmi SK, Herrmann SM, Jensen MD, Jia Q,
Jordan KL, et al: Senolytics decrease senescent cells in humans:
Preliminary report from a clinical trial of Dasatinib plus
Quercetin in individuals with diabetic kidney disease.
EBioMedicine. 47:446–456. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kovacovicova K, Skolnaja M, Heinmaa M,
Mistrik M, Pata P, Pata I, Bartek J and Vinciguerr M: Senolytic
cocktail dasatinib+quercetin (D+Q) does not enhance the efficacy of
senescence-inducing chemotherapy in liver cancer. Front Oncol.
8:4592018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ta NN, Li Y, Schuyler CA, Lopes-Virella MF
and Huang Y: DPP-4 (CD26) inhibitor alogliptin inhibits
TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by
U937 histiocytes. Atherosclerosis. 213:429–435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Amor C, Feucht J, Leibold J, Ho YJ, Zhu C,
Alonso-Curbelo D, Mansilla-Soto J, Boyer JA, Li X, Giavridis T, et
al: Senolytic CAR T cells reverse senescence-associated
pathologies. Nature. 583:127–132. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Childs BG, Gluscevic M, Baker DJ, Laberge
RM, Marquess D, Dananberg J and van Deursen JM: Senescent cells: An
emerging target for diseases of ageing. Nat Rev Drug Discov.
16:718–735. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhu Y, Doornebal EJ, Pirtskhalava T,
Giorgadze N, Wentworth M, Fuhrmann-Stroissnigg H, Niedernhofer LJ,
Robbins PD, Tchkonia T and Kirkland JL: New agents that target
senescent cells: The flavone, fisetin, and the BCL-XL inhibitors,
A1331852 and A1155463. Aging (Albany NY). 9:955–963. 2017.
View Article : Google Scholar
|
|
54
|
Kirkland JL, Tamara T, Yi Z, Niedernhofer
LJ and Robbins PD: The clinical potential of senolytic drugs. J Am
Geriatr Soc. 65:2297–2301. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Jeon OH, Kim C, Laberge RM, Demaria M,
Rathod S, Vasserot AP, Chung JW, Kim DH, Poon Y, David N, et al:
Local clearance of senescent cells attenuates the development of
post-traumatic osteoarthritis and creates a pro-regenerative
environment. Nat Med. 23:775–781. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Justice JN, Nambiar AM, Tchkonia T,
LeBrasseur NK, Pascual R, Hashmi SK, Prata L, Masternak MM,
Kritchevsky SB, Musi N and Kirkland JL: Senolytics in idiopathic
pulmonary fibrosis: Results from a first-in-human, open-label,
pilot study. EBioMedicine. 40:554–563. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Van Deursen JM: Senolytic therapies for
healthy longevity. Science. 364:636–637. 2019. View Article : Google Scholar : PubMed/NCBI
|
